Evaluating the efficacy and safety of biologic and oral drugs for refractory chronic spontaneous urticaria: systematic review and network meta-analysis
Published: 25 September 2024| Version 2 | DOI: 10.17632/vv86dhyn25.2
Contributors:
YaXuan Zheng, min luo, Jiahao Huang, Marcus Maurer, Huichun SuDescription
NMA supplementary materials Modify "FEN 50 mg BID" and "FEN 150 mg BID" in version 1 to "FEN 50 mg QD" and "FEN 150 mg QD".
Files
Categories
Dermatology, Urticaria, Antihistamine, Emerging Treatment
Funding
Introduction of talent research start-up fund of Fujian Medical University Union Hospital
2021XH026